Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « implications »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
implication < implications < implicit  Facettes :

List of bibliographic references indexed by implications

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000291 (2011) Polly Ambermoon [Australie] ; Adrian Carter [Australie] ; Wayne D. Hall [Australie] ; Nadeeka N. W. Dissanayaka [Australie] ; John D. O'Sullivan [Australie]Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field
000699 (2010) Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne]Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
000778 (2010) Christian Wider [États-Unis] ; Tatiana Foroud [États-Unis] ; Zbigniew K. Wszolek [États-Unis]Clinical implications of gene discovery in Parkinson's disease and parkinsonism
000819 (2010) E. Alfonsi [Italie] ; I M Merlo [Italie] ; M. Ponzio [Italie] ; C. Montomoli [Italie] ; C. Tassorelli [Italie] ; C. Biancardi [Italie] ; A. Lozza [Italie] ; E. Martignoni [Italie]An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment
000C38 (2008) Lars Bertram [États-Unis] ; Rudolph E. Tanzi [États-Unis]Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
000D31 (2008) Maryka Quik [États-Unis] ; Kathryn O'Leary [États-Unis] ; Caroline M. Tanner [États-Unis]Nicotine and Parkinson's disease: Implications for therapy
000D36 (2008) Maria G. Cersosimo [Argentine] ; Eduardo E. Benarroch [États-Unis]Neural control of the gastrointestinal tract: Implications for Parkinson disease
000D50 (2008) Ji-Young Park [Corée du Sud] ; Seung R. Paik [Corée du Sud] ; Ilo Jou [Corée du Sud] ; Sang Myun Park [Corée du Sud]Microglial phagocytosis is enhanced by monomeric α‐synuclein, not aggregated α‐synuclein: Implications for Parkinson's disease
000E03 (2008) Susan OliverExploring the healthcare journey of patients with rheumatoid arthritis: A mapping project – implications for practice
001282 (2006) Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Giovanni Savettieri [Italie]Implications for Estrogens in Parkinson's Disease
001365 (2006) Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications
001468 (2005) Katherine A. Grosset [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni]Medicine‐taking behavior: Implications of suboptimal compliance in Parkinson's disease
001612 (2004) Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias
001C10 (2000) J. M. Henderson [Australie] ; K. Carpenter [Australie] ; H. Cartwright [Australie] ; G. M. Halliday [Australie]Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications
001C18 (2000) R. J Schulingkamp [États-Unis] ; T. C Pagano [États-Unis] ; D. Hung [États-Unis] ; R. B Raffa [États-Unis]Insulin receptors and insulin action in the brain: review and clinical implications
001D64 (1999) Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis]Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention
001E05 (1999) Bernard Belhassen [Israël] ; Sami Viskin [Israël] ; Roman Fish [Israël] ; Aharon Glick [Israël] ; Michael Glikson [Israël] ; Michael Eldar [Israël]Catheter-induced mechanical trauma to accessory pathways during radiofrequency ablation: incidence, predictors and clinical implications
001E54 (1998) J. Mendlewicz [Belgique]The broad spectrum of comorbid depression: implications for treatment
002029 (1997) Ronn E. Tanel ; Edward P. Walsh ; John K. Triedman ; Michael R. Epstein ; Dennis M. Bergau ; J. Philip SaulFive-year experience with radiofrequency catheter ablation: Implications for management of arrhythmias in pediatric and young adult patients
002354 (1995) Lissy F. Jarvik [États-Unis] ; Steven S. Matsuyama [États-Unis] ; Helena Chui [États-Unis] ; Arnold B. Scheibel [États-Unis] ; Harry V. Vinters [États-Unis]Autopsy diagnoses of Alzheimer disease: Independent reviews and clinical implications
002758 (1990) Schuger ; Russell T. Steinman ; Michael H. Lehmann ; Lucia Schuger ; Deborah Boldea ; Linda Mcmath ; J. Richard SpearsPercutaneous transcatheter laser balloon ablation from the canine coronary sinus: Implications for the Wolff‐Parkinson‐White syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "implications" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "implications" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    implications
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024